Curative pulls in more than $150 mn in Series B capital, pushing its valuation to $1.275 bn and doubling down on an idea the company keeps stressing: health insurance shouldn’t bury people in co-pays and deductibles just to access basic care.
The round signals strong conviction in Curative’s $0-out-of-pocket plan design and its AI-driven member support stack, both of which the team claims can reshape how Americans access and pay for care.
The plan hinges on a simple requirement. Members complete an annual Baseline Visit, and in exchange they get no co-pays, no deductibles, no coinsurance.
That one tweak shifts how people use care. According to Curative’s data, primary-care engagement jumps roughly 20%, hospitalizations drop 30%, and drug spending falls as much as 40% in the first year after an employer joins.
Curative positions itself as a next-wave health insurer, building an employer-based plan that doesn’t resemble the legacy playbook and already carries an AM Best A- rating.
The company’s mission stays blunt: strip away the financial roadblocks that keep people from getting care and guide members through their health needs with a model built to work in real life, not just on paper.
All of it comes from keeping members healthier instead of forcing them to delay care because of cost. Oddly obvious, yet rare in the market.
Fred Turner, Curative’s CEO and co-founder, says the company’s mission focuses on breaking financial barriers and navigating members through their care journey with a mix of AI tools and real human support.
He frames the new funding as fuel to modernize the member experience, enter new states, and scale the model into something brokers and employers can rely on without red tape.
This funding validates the disruptive model we’ve built, which leverages AI-driven technology, real human support, and aligned incentives to actually improve outcomes.
Fred Turner, CEO and co-founder
“We’re accelerating the modernization of the member experience, expanding into new markets, and scaling the impact we know the industry desperately needs. The momentum is real, and employers, brokers, and providers are seeing the value of a plan designed with their success in mind,” Fred Turner noted.
The company already serves 1,200+ employer clients and over 165,000 members, and it’s profitable less than three years after launch.
The investor list reads like a who’s who of tech-forward capital. Chris Anderson’s Upside Vision Fund leads, while Justin Mateen – Curative’s first investor, doubles down with $47.5 mn personally and through JAM Fund. Mateen’s early stake has compounded more than 400x, and he still wants more.
He says Curative “reimagines health insurance from first principles,” a phrase investors use when they think a founder is tackling a problem others avoid.
Additional backers include Mike Novogratz, the Duquesne Family Office, DCVC and Martin Varsavsky. Anderson calls the company’s speed “exhilarating,” especially given how misaligned incentives usually slow the sector to a crawl.
Curative intends to use the capital to expand nationally, with the Mid-Atlantic states next in line.
Growth means beefing up reserves to satisfy regulatory demands and protect long-term financial strength, plus heavier investment in AI-driven operations, deeper member-engagement efforts, and network development that cuts administrative drag.
The network strategy might be the most radical part. Curative argues traditional networks restrict access and obscure pricing. Its answer is the Curative Cash Card, a mechanism that widens access to $0 care across more than a million providers nationwide.
Members get predictable, frictionless transactions, no surprise bills, no maze of denials. Providers get instant payment at the point of care, which dismantles a big chunk of administrative waste baked into legacy systems.
According to Beinsure data, carriers have discussed similar features for years, but execution always stalled.
Turner says the sector’s long-running frustration over complexity and rising costs has finally hit a turning point, and employers now want simplicity and predictability more than anything.
Curative sees that shift as its opening. Maybe the timing really is right. The BUCA incumbents aren’t built to spin up a national $0-cost model quickly, and Curative is betting that gap leaves enough space for a challenger with momentum.
